Stanley Capital-Backed Portfolio Company DSS Acquires MyMeds&Me

Published on: 

Stanley Capital Partners LLP (SCP) announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a global provider of pharmacovigilance services under the brand Bioclinica. The financial terms of the transaction are not being disclosed.

The combined, digital-first organization will provide a pharmacovigilance solution focused on the current and future requirements of the life sciences industry.


Read more about the acquisiton here.